Wang Ting, Yang Jin, Yang Fanping, Cheng Ye, Huang Zichong, Li Bei, Yang Linlin, Xing Qinghe, Luo Xiaoqun
Children's Hospital of Fudan University, Institutes of Biomedical Sciences of Fudan, Shanghai, China.
Department of Allergy and Immunology, Huashan Hospital, Fudan University, Shanghai, China.
Front Pharmacol. 2024 May 28;15:1400239. doi: 10.3389/fphar.2024.1400239. eCollection 2024.
Amoxicillin (AMX) is among the most prescribed and the best tolerated antimicrobials worldwide. However, it can occasionally trigger severe cutaneous adverse reactions (SCAR) with a significant morbidity and mortality. The genetic factors that may be relevant to AMX-induced SCAR (AMX-SCAR) remain unclear. Identification of the genetic risk factor may prevent patients from the risk of AMX exposure and resume therapy with other falsely implicated drugs.
Four patients with AMX-SCAR, 1,000 population control and 100 AMX-tolerant individuals were enrolled in this study. Both exome-wide and HLA-based association studies were conducted. Molecular docking analysis was employed to simulate the interactions between AMX and risk HLA proteins.
Compared with AMX-tolerant controls, a significant association of with AMX-SCAR was validated [odds ratio (OR) = 22.9, 95% confidence interval (CI): 1.68-1275.67; = 7.34 × 10]. Moreover, 75% carriers of in four patients with AMX-SCAR, and the carrier frequency of 10.7% in 1,000 control individuals and 11.0% in 100 AMX-tolerant controls, respectively. Within HLA-B protein, the S140 present in all cases and demonstrated the strongest association with AMX-SCAR [OR = 53.5, = 5.18 × 10]. Molecular docking results also confirmed the interaction between AMX and S140 of the HLA-B protein, thus eliminating the false-positive results during in association analysis.
Our findings suggest that genetic susceptibility may be involved in the development of AMX-SCAR in Han Chinese. However, whether the HLA-B variants observed in this study can be used as an effective genetic marker of AMX-induced SCAR still needs to be further explored in larger cohort studies and other ethnic populations.
阿莫西林(AMX)是全球处方量最大且耐受性最佳的抗菌药物之一。然而,它偶尔会引发严重的皮肤不良反应(SCAR),具有显著的发病率和死亡率。与阿莫西林诱发的SCAR(AMX - SCAR)可能相关的遗传因素仍不清楚。识别遗传风险因素可使患者避免阿莫西林暴露风险,并恢复使用其他被错误牵连药物的治疗。
本研究纳入了4例AMX - SCAR患者、1000名人群对照和100名阿莫西林耐受个体。进行了全外显子组和基于HLA的关联研究。采用分子对接分析模拟AMX与风险HLA蛋白之间的相互作用。
与阿莫西林耐受对照相比,验证了 与AMX - SCAR存在显著关联[比值比(OR)= 22.9,95%置信区间(CI):1.68 - 1275.67; = 7.34 × 10]。此外,4例AMX - SCAR患者中75%为 的携带者,1000名对照个体中的携带者频率为10.7%,100名阿莫西林耐受对照中的携带者频率为11.0%。在HLA - B蛋白中,所有病例均存在S140,且与AMX - SCAR的关联最强[OR = 53.5, = 5.18 × 10]。分子对接结果也证实了AMX与HLA - B蛋白的S140之间的相互作用,从而消除了关联分析中的假阳性结果。
我们的研究结果表明,遗传易感性可能参与了汉族人群AMX - SCAR的发生发展。然而,本研究中观察到的HLA - B变异体是否可作为AMX诱发SCAR的有效遗传标志物,仍需在更大规模的队列研究和其他种族人群中进一步探索。